Search

Search Constraints

You searched for: Author/Creator Guida, Annalisa

Search Results

1. Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer. (19th March 2019)

2. COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry. (November 2021)

3. COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry. (13th April 2022)

4. Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. Issue 4 (7th April 2021)

6. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. Issue 7 (July 2022)

7. Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. (May 2021)

8. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Issue 12 (December 2021)

9. Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre. (July 2017)

10. Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti‐PD‐1 therapy. Issue 7 (4th May 2022)